Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge technology innovation and provider of integrated solutions from “Idea to IND”, announced it has entered into a collaboration agreement with ExeVir Bio.
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio Read More »
Curis, Inc. announced that on March 31, 2023, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 135,450 shares of Curis common stock to a new employee, with a grant date of March 31, 2023.
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) – April 06, 2023 Read More »
Innate Pharma SA announced the filing of its 2022 Universal Registration Document for the year ending December 31, 2022 with the French market authority “Autorité des Marchés Financiers” on April 6, 2023.
Ochre Bio, an innovator in chronic liver disease medicine development, is pleased to announce the appointment of David Coughlan, PhD as VP of Translational Development and Chinwe Ukomadu, MD, PhD as an Observer on its Board of Directors.
In today’s global economy, businesses are increasingly expanding beyond their home countries and hiring employees across borders. This presents a challenge when it comes to managing payroll, as each country has its own unique payroll regulations and tax requirements. That’s wher …
International Payroll: How to Find the Best Payroll Services Providers Read More »
Last week, the Biden Administration filed a notice to appeal a federal court ruling that blocked the ACA mandate that requires health plans to fully cover preventative medical services like cancer, HIV and diabetes screenings.
Some patients still pay for ACA-mandated free preventative care, study finds Read More »
The analysts expect Medtronic to “find a place in specific markets” that Intuitive is yet to dominate.
In a letter to Illumina shareholders, Icahn says the two companies “should be separated immediately” to protect the “long term growth prospects and viability of each.”
Icahn ramps up rhetoric on Illumina after FTC orders Grail sale Read More »
The former CEO and two other top executives of Magellan Diagnostics are accused of hiding a malfunction that caused tens of thousands of children and other patients to receive inaccurately low lead test results.
Diagnostics execs charged with concealing lead test flaw Read More »
Legislators recently reintroduced the VALID Act, which would bring lab-developed tests and in-vitro diagnostics under one framework, after failing to pass the bill twice last year.
Diagnostic testing reform bill has a path to the finish line this year: AdvaMed Read More »
